abstract |
The invention week 41 as a dopamine D 1 and D 2 receptors, for the treatment of disorders of the central nervous system to the dose plan as having activity at serotonin 5HT 2 receptors - ((1R, 3S) -6- chloro-3 -Phenyl-indan-1-yl) -1,2,2-trimethyl-piperazine and salts thereof. |